Wyniki wyszukiwania - Biblioteka Nauki

1

Atroposelektywna synteza naturalnych chiralnych osiowo związków biarylowych. Część 1

100%

Kołodziejska R. , Tafelska-Kaczmarek A. , Studzińska R.

|

tom [Z] 71, 3-4

177--197

EN

In early twentieth century, it was already known that chemical compounds might be chiral without containing the chiral atoms. The presence of the stereogenic center is a sufficient but not necessary condition that the molecule appears in two forms which are mirror images. In certain cases, the limit of free rotation in the molecule may result in asymmetry, e.g. inhibition of rotation around single bond leads to axial isomers. This is the kind of conformational isomerism, which according to the nomenclature is called atropisomerism [1, 2]. The most often optically active molecules without stereogenic atoms, possessing an axial chirality are biaryls, which are commonly found in nature. In most cases, pharmacological activity of biaryls is associated with the presence of axial chirality (Figs 1, 2; Scheme 1) [1–14]. Generally chiral biaryls are divided into bridged biaryls (Scheme 4–6) [15–24], and biaryls, which do not contain the additional ring (Scheme 2, 3) [25–33]. The thermal stability of both enantiomeric/diastereomeric forms is an essential precondition for atropisomerism. For a given temperature, conformationally stable isomers may coexist when their a half-life is at least 1000 s, which gives the minimum energy barrier of 93 kJ mol–1 at 300 K. Chiral biaryls can be achieved by either desymmetrization of stable but achiral biaryls by modifying one of the groups on the aromatic moiety (Scheme 7–9) [1, 34, 35], or by dynamic kinetic resolution of racemic mixtures of the conformationally unstable chiral substrates. The synthesis of the chirally stable biaryls from the chiral labile substrates is most frequently the result of the extra substituent addition (Scheme 10) [36], and formation or cleavage of a bridge (Scheme 11–16) [37–54]. The axially chiral biaryls can also be obtained in the atroposelective transformation of the alkyl substituent of the arene ring into a second aromatic ring in the presence of an organometallic catalyst (Scheme 17, 18) [55, 56].

2

Prolina – pospolity aminokwas wyjątkowy katalizator. Część II, Międzycząsteczkowa kondensacja aldolowa

88%

Kołodziejska R. , Wróblewski M. , Karczmarska-Wódzka A. , Studzińska R. , Dramiński M.

|

tom [Z] 67, 11-12

1027--1050

EN

Proline in organic synthesis is used as a small molecular organocatalyst. In a catalytic act proline, similarly to an enzyme, activates reagents, stabilizes transition state and influences an orientation of substrates [1–12]. Proline works as aldolase I (so called microaldolase I). In comparison with other amino acids it shows exceptional nucleophilicity which makes imines and enamines formation easier. In the intermolecular aldol reaction proline was used for the first time by List and co-workers (Scheme 1) [3, 9, 20]. Since then an immense progress has been observed in this field. Several aldolization reactions were performed in the presence of proline. Reactions of this type proceed between the donor (nucleophile) and the acceptor (electrophile). In aldol reaction the donors can be both ketones and aldehydes which next are condensed with ketones and aldehydes acting as electrophiles (Scheme 2–18; Tab. 1–7) [21–72]. The presence of proline ensures not only high yield of homo- and heteroaldolization but mainly enables conducting enantio- and diastereoselective synthesis. Intermolecular proline-catalyzed aldol condensation proceeds according to enamine mechanism. Anti-aldols, which make a valuable source of intermediates in the synthesis of important biologically active compounds, are mainly obtained in this reaction [35–44, 54, 58, 62, 63, 68, 69, 71].

3

Enancjoselektywna enzymatyczna desymetryzacja katalizowana oksydoreduktazami. Reakcje redukcji. Część 2

75%

Kołodziejska R. , Karczmarska-Wódzka A. , Tafelska-Kaczmarek A. , Studzińska R. , Wróblewski M. , Augustyńska B.

|

tom [Z] 68, 11-12

1009--1030

EN

Biotransformation reactions of many organic compounds under the influence of enzymes take place with the high selectivity, rarely achieved by other methods. Ketoesters represent an extensive group of selectively bioreduced compounds. Chiral hydroxyesters and, subsequently, hydroxyacids are valuable intermediates in the syntheses of various biologically active compounds. Acyclic α- and β-ketoesters are transformed to the corresponding (R)- and (S)-hydroxyesters by using a specific dehydrogenases. The whole-cells enzymes, e.g. baker’s yeast, may exhibit a different catalytic activity depending on the substrate structure. Baker’s yeast enzymes selectively reduce the cyclic β-ketoesters providing mainly anti diastereomers due to the lack of rotation around the single α,β carbon-carbon bond. The enzymatic reduction of the esters, cyclopentanone, and cyclohexanone derivatives gave the optically active anti-alcohol enantiomers. The reductive EED of prochiral α-ketoesters, as well as β-ketoesters is an interesting transformation in organic chemistry due to the importance of the resulting chiral α-hydroxy acids and their derivatives used as building blocks. Baker’s yeast-catalyzed reduction of alkyl esters derived from pyruvate and benzoylformate allows the preparation of the (R)-alcohols. Polyketones can also be subjected to the reductive EED to give different compounds bearing the quaternary stereogenic centers which are broadly applied in asymmetric synthesis. In asymmetric synthesis, similarly to carbon-oxygen double bonds, carbon-carbon double bonds of prochiral alkanes can be reduced to obtain the optically active saturated compounds. The reduction of alkenes is catalyzed by both, the whole cells (microorganisms, plant cells) as well as isolated enzymes belonging to the oxydoreductases, so-called ene-reductases. The whole-cell catalysts are suitable, most frequently, for the preparative scale syntheses, but they are less chemoselective in comparison to the isolated reductases. In the case of polyfunctionalized alkenes, microorganisms can cause the additional side reaction reducing the desired product yield.

4

Enancjoselektywna enzymatyczna desymetryzacja katalizowana oksydoreduktazami. Dehydrogenazy w reakcji redukcji. Część I

75%

Kołodziejska R. , Karczmarska-Wódzka A. , Tafelska-Kaczmarek A. , Studzińska R. , Wróblewski M. , Augustyńska B.

|

tom [Z] 68, 9-10

763--782

EN

Enzymes act as biocatalysts whether are also mediating in all anabolic and catabolic pathways, playing an extremely important role in the cells of all life forms. Catalytic potential of oxidoreductases is most commonly used in reduction reactions. Dehydrogenases and reductases catalyze the reversible desymmetrization reactions of meso and prochiral carbonyl compounds and alkenes. The oxidoreductase- catalyzed reactions require cofactors to initiate catalysis. In most cases, it is nicotinamide adenine dinucleotide (NADH) or its phosphorylated derivative (NADPH), which acts as a hydride donor. The necessity of employing expensive cofactors was, for the long time, one of the main limitations to the use of dehydrogenases. This problem was solved by developing a regeneration system of a cofactor in the reaction environment. Various systems are used for the cofactor recycling. In the case of a carbonyl compound reduction, an irreversible oxidation of formic acid to carbon dioxide is most frequently used. In this paper, selected examples of whole-cell and isolated enzymes applications in the carbonyl compound reduction are discussed. The application of baker’s yeast, microorganisms and dehydrogenases in enantioselective enzymatic desymmetrization (EED) of prochiral ketones leads to a broad spectrum of chiral alcohols used as intermediates in the syntheses of many pharmaceuticals and compounds presenting a potential biological activity.